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I always knew that one day the phone call would 
come. I just could not imagine processing the news 
and hanging up the phone. Like most physicians, 
I have delivered news of the death of a loved one 
and have been at the bedside when families were 
holding vigil. Many years ago, as a house officer,  
I participated in the prolonged care of persons 
whose case was hopeless from the start. None  
of this prepared me for the call about my dad’s 
death this past winter.
My dad’s passing, and my thoughts about his death, 
have given new meaning and motivation to my new 
role as Dean. I am more motivated today than ever 
to ensure that health care professionals are trained 
to work together to provide the most appropriate 
care and support to their patients.
There is a robust literature by physicians writing 
about the death of their parents and it seems to be 
especially focused on the death of the father.1,2,3  
I had been collecting some of these essays and even 
shared them with my dad over the years, hoping he 
would understand the role of a physician son and 
the difficult decisions that families face as elderly 
loved ones become frail, cognitively impaired, and 
severely ill.
My father was the middle son of three brothers, 
born just before the Great Depression to immigrant, 
non-English speaking parents on the Lower East 
Side of Manhattan. He went to kindergarten 
speaking only Yiddish and had to quickly learn the 
language. My grandmother, a widow most of her 
life, did not read or write English. Although he  
was raised in a single parent household on welfare,  
as an adult he was relentlessly upbeat.
Other aspects of my dad’s childhood may sound 
familiar to children of first-generation Americans: 
the rapid road toward assimilation, with education 
as the escape valve from the ghetto. My father was a 
well educated man. He graduated from the Cooper 
Union in New York City and eventually attended the 
first class of the Sloan School of Management at the 
Massachusetts Institute of Technology. He became 
an entrepreneur, creating a successful business from 
scratch that eventually went public. His business 
acumen was all “relationship based,” flowing from 
his uncanny ability to make friends. 
My father never lost his temper and always 
encouraged my brother and me in our various 
pursuits, especially those related to school. 
He instilled in us a sense of pride in our 
accomplishments, patriotism for our country, and 
a belief that the future held limitless possibilities. 
His most cherished role was that of grandparent. 
Nothing brought him more pleasure than extended 
family vacations and other life events like bat 
mitzvahs, weddings, and the like. He truly reveled  
in the company of his five grandchildren and, 
despite protestations from my mother, tried hard  
to spoil all of them mercilessly. 
Before his death, I encouraged Dad to undertake a 
project to write his memoirs and contracted with 
Mary O’Brien Tyrell, a writer in Minneapolis, to 
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help him with the task. Ms. Tyrell visited with him, 
listened carefully to the story of his life, and helped 
him to document it for posterity. 
I had some trepidation in creating this contractual 
relationship between my dad and Ms. Tyrell. Stories 
abound whereby elderly men, in particular, focus 
so much on their war-time service and business 
escapades and conveniently nearly forget about 
their wives and children! The project took nearly 
two years of work, but I was grateful that my father 
eventually saw it through. Ironically, the package 
containing the forty hardcover copies of his 
memoirs arrived on the evening of the day he died. 
It became a prized – and instant – family heirloom.
How does all of this relate to my motivation for our 
new school?   Here’s the medical side of the story. 
Two weeks prior to his death, my dad suffered a 
small cerebral hemorrhage and was hospitalized 
in a local community hospital near his home in 
southeast Florida. I had an opportunity to visit 
him in the hospital, where he recovered quickly. 
Although he suffered no long-term motor problems, 
he clearly was left with some cognitive deficits. 
During his stay in the hospital, my physician 
brother and I attempted to communicate with 
the multiple consultants who were caring for our 
father. As the number of consultants increased, the 
communication became more fractionated. Our 
non-system is so fragmented and poorly designed 
that I can only imagine the frustration encountered 
by family members without a clinical background 
during the hospitalization of a loved one. My 
dad suffered a hospital-acquired infection that 
derailed his overall care plan until he was finally 
discharged after a nearly two-week stay in the 
hospital. His discharge coincided with our family 
December holiday vacation to Florida, so he had the 
opportunity to visit with all of his grandchildren. 
The very next day, I got the dreaded phone call that 
he had died in bed at home.
As a son and physician, I am grateful for some of 
the blessings of the brief time period between his 
illness and his death. 
First and foremost, my dad had an opportunity to 
see all of his grandchildren while he was still able 
to carry on a conversation and to sit at the table 
for a family meal. He avoided a re-hospitalization, 
whereby my brother and I would have undoubtedly 
had to make difficult decisions regarding ceasing 
intubation, life support and related medical 
intervention, something he never would have 
wanted to endure. 
The arrival of his memoirs, within hours of his 
death, was just like my dad – waiting till the last 
minute to complete a project. Regrettably, he never 
got to actually hold the book in his hands.
I am also grateful that we avoided what many 
families increasingly face – that is, according 
to Winakur2, the American narrative “of aging, 
disability and dementia that is played out in your 
family, in your home, when the numbers, the data, 
the statistics become your loved ones, your spouse, 
your parents and then yourself, you will finally 
understand how wrong-headed so much of current 
public healthcare policy is today.”  
Delivering the eulogy at his funeral, I noted that my 
brother and I and our wives – all physicians – were 
grateful that my father did not endure a prolonged 
hospitalization with all sorts of unnecessary testing, 
consultation, and the like. I could see many of 
the white-haired heads all nodding in vigorous 
agreement as I expounded upon our gratitude that 
a final bedside vigil never became necessary. My 
heart ached for all of the families whom I know 
have had to endure just such a vigil, and I felt a  
wave of relief knowing what could have been. 
So there you have it. I’m grateful, saddened, and 
feel a big hole in my heart. Paradoxically, I am 
also energized, motivated and excited about my 
work and our new school. More than ever before, 
I am committed to helping to fix this mess so 
that other families will get a sense of patient-
centeredness, better coordination of care, and 
better communication from their doctors and other 
caregivers. As Bobrow3 has noted, “parents must 
die before their children and so my father passed 
in accordance with his wishes without ever having 
used a cane or a walker or ever having to rely on 
anyone other than close friends or family.”  
While my dad’s death was unexpected, his passing 
was quick enough to burden no one. After sixty 
years of marriage my mom is lonely, but she is 
grateful for his lack of suffering. The enduring 
lessons of my dad’s life remain as an important 
guidepost for me. His advice was always sought as 
the highest level of family counsel. His intellect and 
his understanding of relationships allowed him to 
grasp the key facts and mollify stakeholders in any 
situation. Clearly, I will need to call upon these skills 
too, as we move forward with some of the possible 
solutions to fix our broken system.   
David B. Nash, MD, MBA 
Dean, Jefferson School of Population Health
As always, I am very interested in your views. You 
can reach me by email at david.nash@jefferson.edu.  
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Stimulus Money and Health Care Research and Investment
On February 17, 2009 the American Recovery 
and Reinvestment Act (ARRA) – or, as commonly 
referred to in the media, the Stimulus Bill – was 
signed into law. The legislation allocates $787 
billion for federal stimulus spending in an attempt 
to curb the current economic recession. Of the 
total, $150 billion has been allocated to health 
care (Figure 1). Health care represents the largest 
proportion of dedicated funds as well as the 
largest sector of the economy.1 Thus, recovery and 
well-being of the economy is inexorably tied to 
the condition of the healthcare industry. The $150 
billion allotment is viewed as the jumping-off 
point for the Obama administration’s healthcare 
agenda, which seeks to increase access to services 
while controlling cost. Because this will have both 
immediate and long-term effects for everyone in 
the nation, it is imperative for all to understand 
the broad health policy implications. 
Over half (58%) of the health care stimulus  
funds – $87 billion– will be devoted to states 
in the form of matching federal assistance for 
Medicaid.2  The remainder of the health care 
stimulus dollars are pegged for three broad 
initiatives: comparative effectiveness research, 
health information technology, and increased 
funding ($10.4 billion) for the National Institutes 
of Health (NIH).2,3  These three initiatives have the 
potential to profoundly affect healthcare policy 
and the future direction of the healthcare industry. 
Specifically, the ARRA apportions $1.1 billion 
for comparative effectiveness research, one of 
the more controversial funding initiatives.2 
Because comparative effectiveness is in its 
nascent stage in the United States, many have 
presupposed its implications and have a deep-
rooted misunderstanding of this form of science. 
In its simplest form, comparative effectiveness 
research can be boiled down to the comparison of 
alternative treatments for a medical condition to 
determine the best overall treatment strategy. 4  
In practice, it is not this simple; there are many 
methodological and policy challenges. Foremost, 
researchers must determine the appropriate 
outcome measure for which to compare distinct 
or contrasting interventions. Another important 
component of comparative effectiveness research 
is economic evaluations of interventions. However, 
interventions which improve health outcomes 
do not always save money and, in fact, can be 
significantly more expensive than the current 
standard of care. As such, policy makers are forced 
to determine at what costs they are willing to fund 
interventions which improve healthcare. 
While there are clear methodological and 
political challenges to conducting comparative 
effectiveness research, it should not be discounted 
nor touted as the savior of health reform. Rather, 
when implemented as part of an overall evidence-
based medicine agenda, comparative effectiveness 
research has the potential to curb rampant health 
care inflation and improve overall quality of care. 
To oversee funding of comparative effectiveness 
research and to help alleviate the fear of the 
government using findings from this type of 
research to directly dictate medical coverage,  
the Federal Coordinating Council for Comparative 
Effectiveness Research (FCC-CER) was established 
on March 19, 2009. Comprised of a 15-member 
expert panel, the FCC-CER role is to submit reports 
to Congress on the comparative effectiveness 
research being conducted; it will not be able to 
mandate coverage or set healthcare policy.1,4 
The health care appropriation will also direct 
$19.2 billion to healthcare technology and 
infrastructure investments with the ultimate  
goal of the implementation of an electronic  
health record for every person in the United  
States by 2014.2 To achieve this goal, the funds
will initially be used to provide incentives 
to doctors and hospitals to adopt the use of 
electronic health records.1 
The money will also be used to train workers in 
the use of health information technology and 
improve the security of electronic health records. 
Finally, the legislation allocates an additional 
$10.4 billion to NIH (approximately 1/3 of the 
current NIH budget), which must be spent in  
two years.2,3 Of the total, $2.2 billion is dedicated to 
capital improvements of facilities, infrastructure 
and equipment to improve healthcare 
infrastructure and provide jobs as a way to 
stimulate the economy. The remaining $8.2 billion 
is intended for peer-reviewed research grants.2  
This tidal wave of money devoted to health care 
marks the beginning of a new era in health 
policy, where costs are controlled and quality is 
demanded. Innovation is imperative, and novel 
ideas and approaches to solving the health care 
crisis are welcomed from all disciplines. In order 
to sustain lasting improvement, policy makers 
must remember to continue to invest in the 
nation’s healthcare system after the stimulus 
funds expire.   
Eric Jutkowitz 
Post-Baccalaureate Fellow  
Jefferson School of Population Health 
Figure 1: Allocation of Health Care  
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Jefferson Students’ Improving Knowledge of Issues in Health Policy
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2009 Annual Quality/Risk Management Retreat:  
An Approach to Patient Safety
The Jefferson Health System (JHS) Quality Council 
and Mountain Laurel RRG Risk Management  
Committee hosted, An Approach to Patient Safety, 
a Quality/Risk Management Educational Retreat  
on April 22, 2009.  The featured speaker for the 
event was Peter Pronovost, MD, PhD, FCCM, the 
Director of the Johns Hopkins University Center  
for Innovation in Quality Patient Care and author 
of more than 200 articles and chapters in the  
fields of patient safety, quality health care, and 
evidence-based medicine. 
Dr. Pronovost’s presentation was organized into  
two sections. The first half of the program was 
dedicated to the issues and problems in appro-
priately measuring patient safety. It is critical to 
understand how and what to measure in order to 
provide a clear and accurate picture of what is  
going on. He spoke about learning from mistakes, 
and described teamwork tools, including daily 
goals, morning briefings, shadowing, active 
 listening, and culture check-ups. He also discussed 
difficulties in translating evidence into practice.
In the second half of the program Dr. Pronovost 
spoke about strategies that can be used to improve 
patient safety. He explored attitudes, culture, and 
methods that are required to make substantial 
progress in improving patient safety within 
healthcare organizations. He stressed the use of a 
conceptual model based on structure, process and 
outcome to provide a context and culture of safety. 
In particular, he spoke about how he approaches  
the “Science of Safety” by including both  
measurement issues and strategies to get  
interdisciplinary groups to work together to  
improve system performance. 
Dr. Pronovost described some of the projects in 
which he is involved, including several that focus 
on improving care in Intensive Care Units (ICUs).  
For example, he described a patient safety score-
card that he and his colleagues have developed  
and used as a framework for safety improvement  
in the ICU (refer to Table 1). 1
Domain  Definition 
How often did we harm patients?  Measures of health care-acquired infections
How often do we use evidence-based medicine?  Percentage of patients who receive evidence-  
  based interventions
How do we know we learned from our mistakes? Percentage of months per year the ICU learns   
  from mistakes
How well have we created a culture of safety?     Annual assessment of safety culture at the  
  unit level
It was especially interesting to see how Pronovost’s 
approach takes into account both the technical 
(evidence-based) aspects of patient safety, as well 
as the behavioral/cultural aspects of instituting 
change within work groups that are part of a  
larger organization. By using such an approach,  
one can examine changes from several perspectives, 
including the changes in structure, process, and 
outcomes that result from an effort to change safety 
within an ICU.   
For resources, training modules, and toolkits 
related to this topic, visit: www.safercare.net.
Table 1: Patient Safety Scorecard
Peter J. Pronovost, MD, PhD, FCCM 
Professor, Johns Hopkins University School of Medicine 
Medical Director, Center for Innovation in Quality Patient Care
April 22, 2009
Annual expenditures on health care in the US 
exceed $2 trillion.1 The organization and financing 
of the healthcare system have a major impact on the 
practice of medicine, patients’ expectations,  
and outcomes. How well do Jefferson Medical  
College (JMC) students understand the US 
healthcare system at the beginning of their  
medical education?  Has this changed over time?  
How does this compare to students in the Master  
of Public Health (MPH) program?  
A recent national survey of medical students 
identified gaps in their knowledge of important 
issues facing the US healthcare system.2  Using the 
audience response system, 13 selected multiple-
choice items from the national survey were 
administered to first-year JMC students on the 
first day of a series of lectures introducing the 
organization and financing of the US healthcare 
system and to MPH students enrolled in PH 508: 
Health Policy – An International Perspective.  
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How did you score? Test your knowledge. See page 11 for the answers.
Table 1 offers a sample of the exam items, while 
Table 2 provides a summary of the results. 
While this type of casual sample is certainly 
not conclusive, it appears that there is a trend of 
improving scores. JMC students performed better 
than their national peers in 2005, 2006, and 2007.  
JMC students in the fall of 2008 and Jefferson 
MPH students who responded to the same items 
in January 2009 scored substantially better than 
their peers from the earlier years.
How well did the students perform on specific 
items?  In 2005-2007, almost 40% of JMC first 
year students incorrectly believed that the United 
States has a lower infant mortality rate than any 
other nation in the world. In the fall 2008 and 
January 2009 exam, 80% of both JMC and MPH 
students responded correctly. On the item asking 
about health care spending, by 2008, over 90% 
of students knew that the US spends more per 
capita on health care than any other country in 
the world. 
When asked to estimate the approximate number 
of people in the US without health insurance, two-
thirds of the MPH students knew that the correct 
response is between 40 and 50 million; less than 
50% of the most recent class of JMC students 
responded correctly. In earlier years JMC students 
had even more significantly underestimating the 
number of people without health insurance. In all 
years, almost all of our students did demonstrate 
an understanding of some of the consequences 
of lack of health insurance such as not having 
a regular source of care, having avoidable 
hospitalizations for diseases such as asthma and 
diabetes mellitus, and delayed diagnosis of cancer.
Why have the scores improved over time?  Perhaps 
all the attention paid to healthcare in the fall 2008 
presidential campaign heightened our students’ 
knowledge of some of the important issues facing 
the US healthcare system. Hopefully, proposed 
reforms to the US healthcare system will make the 
current exam items obsolete.    
Daniel Z. Louis, MS
Research Associate Professor, Family and 
Community Medicine 
Managing Director, Center for Research in 
Medical Education and Health Care 
Jefferson Medical College
Table 2: % Correct Responses on Selected Items Concerning the US Healthcare System
 68% 72% 72% 73% 79% 80%
Note: There were 21 student respondents from the MPH class. The JMC entering class size is 255. 
Not all students were in attendance and not all responded to every item. 
Results from  
national survey 
published in  
Academic Medicine
Jefferson Medical College – 1st year students
Jefferson  
MPH students  
Jan 2009Fall 2005  Fall 2006 Fall 2007 Fall 2008
Table 1: Student Knowledge Exam Items
1.   The United States has a higher life 
expectancy than any other nation in  
the world. 
2.   The United States has a lower infant  
mortality rate than any other nation in  
the world.
3.   Government-administered health  
insurance (e.g., Medicare) requires more 
money per person for administrative  
costs than private health insurance. 
4.   The United States is the only 
industrialized nation in the world not  
to guarantee access to health care for  
all of its citizens.
5.   The United States spends more per 
person on health care annually than any 
other nation in the world.
6.   People without health insurance are 
less likely to have a regular source of  
medical care.
7.   People without health insurance are 
more likely to suffer from avoidable 
hospitalizations for diseases such as 
asthma and diabetes mellitus.
8.   People without health insurance are more 
likely to suffer from delayed diagnoses 
for diseases like cancer.
9.   Most individuals without health 
insurance are in families where no  
one works.
10.   Raising the cost of co-payments or  
deductibles does not affect whether  
patients will go see their doctor.
11.   The number of uninsured individuals  
in the United States increased over  
the last decade.
12.   Where, approximately, did the United 
States rank, out of 191 countries, in a  
2000 World Health Organization 
(WHO) report on “health systems 
performance?” 
 a. Near first place 
 b. Near 10th place 
 c. Near 20th place 
 d. Near 30th Place 
 e. Near 40th place
13.   How many uninsured people are there 
in the United States today?  
 a. Fewer than 10 million 
 b. 10 to 20 million 
 c. 20 to 30 million 
 d. 30 to 40 million 
 e. 40 to 50 million 
 f. Over 50 million
True or False
RefeRences 
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Now that the Clinical Skills Center has been in 
the Hamilton Building for well over a year, what 
type of an impact do you feel that this facility 
has had on the students and their experiences?
KB:  The students are very excited; and it’s also 
been nice for GME. It allows us to expand 
our pre-existing curriculum and evaluation 
tools, to develop in new areas and serve the 
needs of many others. The building provides 
a venue for educators of all disciplines and 
professions to get together and teach and 
develop.  Members of different departments 
are crossing paths and working together in  
an exciting learning environment. 
DB:  One of the fundamental advantages of a 
simulation center is that it provides a 
great venue for getting faculty to markedly 
increase the time spent directly teaching 
students the skills they used to teach at  
the bedside. 
 KB:   The Skills Center team works closely with 
faculty and provides educational consulta-
tion as ideas and programs are developed. 
For example, we work with the clerkship or 
program director to assess and discuss their 
needs; develop a set of teaching objectives; 
and create a plan for product development 
needed to teach the program. Most of the 
time, the faculty will run their individual 
program and we support and provide the 
mechanism to produce it.
DB:  This building is a catalyst for creating a 
collegial, team approach to curriculum  
 development and implementation. It  
allows for cross-pollination from various 
fields and professions. It is a place to learn 
that is safe for the learner, and for the  
simulated patient whether it be a mechanical 
simulator, a human (standardized patient) 
simulation or a hybrid of the two. Teaching 
core skills across professions creates a rich, 
dynamic learning environment. That’s why 
we are so excited that Jefferson Center for  
InterProfessional Education (JCIPE) is  
the cornerstone of this movement, led  
by Christine Arenson, MD and Molly A.  
Rose, PhD, CRNP. 
As faculty, you have the opportunity to observe 
students going through this unique education-
al process. What is that like?
KB:   We teach all 4 years so we do get to see 
how students develop over time. First year 
students come in wide-eyed and nervous;  
by 4th year they are more relaxed. The 
amount of knowledge they acquire in those 
four years is breathtaking. They go from 
being a student to becoming a colleague, 
and get to a point where they are actually 
teaching one other. This is particularly true 
with Jefferson’s unique Advanced Physical 
Diagnosis (APD) course, an elective that 
is immensely popular in the 4th year. 
Approximately 75 students devote one  
month to immersion in the clinical skills 
set of physical examination. The course 
consists of not only learning the skills, 
but interpreting them, applying them to 
clinical situations and then, translating the 
simulation and skills directly to bedside 
learning and teaching through faculty rounds 
with real patients. 
DB:   The APD course helps learners refine their 
skills so they can make clinical decisions in 
the absence of imaging or lab support. In 
those situations, a Jefferson-trained clini-
cian will be able to call upon the skills set 
that requires only a history and physical at 
minimum to provide care to their patients 
and develop a reasonable diagnostic and 
therapeutic paradigm. Our view is that 
because a primary care provider encounters 
undifferentiated problems, he or she must 
master history and physical examination 
with great acumen. 
Describe the feedback, assessment, and  
evaluation process. How is it standardized?  
Is there a variation depending on the program?
KB:   We do both formative and summative 
assessment, at every level. Most of our  
summative assessment is done via  
standardized patients and checklists.  
At the end of the year all 3rd year students 
take an Objective Structured Clinical Exam  
(OSCE), which includes 11 stations of 
standardized patients. The exam consists 
of different scenarios where students must 
exhibit their communication skills, physical 
exam skills, counseling skills, and data  
recording/documentation skills. Students 
who don’t pass must spend a month in a 
remedial course (directed by Dr. Joseph  
Majdan) to get their clinical skills up to our 
standards. The OSCE also provides a venue 
for the students to prepare themselves  for 
the Competitive Exams (CX).
  At the end of the 3rd year clerkship, in  
addition to the Standardized Patient (SP) 
assessment, we also conduct a hybrid of  
the SP and the mechanical simulation. The 
scenarios include an acute process that 
requires the student to put in an IV or NG  
tube, for example. Rather than doing the 
procedure on the SP, the student performs the 
procedure on the model. For instance, in OB/
GYN, for an SP who is “in labor,” the student 
would have to deliver a baby on Noelle™  
(a simulation mannequin that delivers 
babies). The student would also have to com-
municate with the SP during the procedure. 
It’s very difficult to both have the skills, the 
hand-eye coordination, and also communi-
cate to a patient what you need them to do. 
DB:   Jefferson is really in the forefront with this 
innovative hybrid – or, as we like to call it, a 
chimera – model of simulation that combines 
plastic with a human example. For example, 
the cardiopulmonary patient simulator,  
Harvey® gives you in vitro sounds of a 
murmur along with a real patient who  
exhibits that same murmur. 
KB:   Although it has been shown that SPs are 
fairly good at assessing history taking,  
communication skills, and the physical 
exam, we are also studying the effectiveness 
of having the SP grade the students on their 
technique of a procedure.
Would the SPs need more training in order to 
achieve that?  
KB:    Yes. We record all the sessions. We also have 
another standardized patient simultaneously  
evaluating the SP’s performance. In other 
words, there is somebody behind the mirror 
The University Clinical Skills and Simulation Center: A Jefferson Gem 
Part II: Interview with Dale Berg, MD and Katherine Berg, MD 
Co-Directors of the University Clinical Skills and Simulation Center (UCSSC)
or behind the curtain, and we have somebody 
who is watching the scenario on tape in real 
time. They both complete the same checklist. 
We compare responses to determine how 
closely they coordinate. Observation in real 
time is preferred over the SP who is with the 
student and completes the checklist after  
the student leaves the room. 
DB:   Using checklists, faculty leaders supervise 
and set exacting standards for training these 
SPs. There are specific steps and nuances in 
physical examination and history taking that 
we expect our second year students to be able 
to perform. After their training at the Center, 
the SPs know these steps and become an 
extraordinary resource for teaching. We like 
to think of them as teacher extenders in that 
they assist the faculty in teaching the skills 
set in a humanistic yet controlled way. 
Are the scenarios used constantly evolving?
DB:    The Center allows us to effectively 
democratize the process of developing 
simulation support and curriculum for 
various programs across the University and 
in the region. Faculty with ideas for projects, 
programs, and research come in from any 
department, source or site on campus 
and we work with them to implement a 
program based on their ideas. We will sit 
down together to create a template, come 
up with ideas and then write a screenplay; 
or, if they want to write a script, we help to 
edit it so that we can produce it. With the 
assistance and expertise of Rob Hargraves, 
managing producer of Jeff Players, and a 
cinematographer from the Jefferson Medical 
Media Department, we write a screenplay, 
cast actors, set up a credible stage, rehearse, 
and then produce and edit. A prime example 
is the series on teaching conflict resolution in 
the ER, which we developed in collaboration 
with Alan Forstater, MD, of Emergency 
Medicine. Of the 11 different scenarios 
shared by Dr. Forstater, we have 5 available as 
professional quality video clips for teaching 
and role modeling purposes. Using our Jeff  
Players acting and production group, we have 
created a library of over 45 competency-
based professional quality teaching video 
trigger clips. 
How do we know if the use of simulation and 
SPs make a difference in outcome?    
KB:   That is the big question nationwide and 
many studies are being proposed. Most of the 
research done has been qualitative: “yes,  
I feel better; yes, I feel more prepared; yes, I 
think this is a good curriculum.” While the 
jury is still out, I think that it does make a 
difference, especially in terms of confidence.
DB:   The policy of the University Simulation 
and Clinical Skills Center (UCSSC) is that 
educational research should be conducted on 
new programs with an eye toward publish-
ing the results. This will thus increase the 
credibility of our teaching and of our Center. 
We are currently working with Ed Jasper, MD, 
Clinical Assistant Professor and Director of 
Emergency Medical Services, to develop a 
scientific assembly for the fall of this year.
KB:   We try to perform qualitative and quantita-
tive research. We have had many abstracts 
and presentations accepted to national, 
international and regional meetings over the 
past year. More research projects are planned 
for the future. 
DB:   We are lucky to have resources like the Center 
for Research in Medical Education (CRIME) 
and, in particular, J. Jon Veloski, MS, who is 
the Director of Medical Education Research 
at the Center and a distinguished researcher 
in this field. Together, we work with faculty 
at our UCSSC research meeting to develop 
research protocols, and foster collaborative 
writing and scientific thinking of methods 
for teaching and uses of specific clinical  
skills sets.
What else would you like our readers to know?  
KB:   I would modify the old model of see one, 
do one, teach one – it’s see one, practice one 
and simulation, do one, teach one. We are 
not trying to supplant the whole idea of 
patient-centered medical education,  we are 
just trying to add that little practice step.
DB:   This is the 21st century iteration of providing 
training and practice to a new generation 
of health care providers. Simulation allows 
a teacher to develop metaphors in innova-
tive ways and provides the opportunity to 
collaborate with others on campus with a 
zest for teaching and learning. This is a place 
where educational research is going to take 
off. Jefferson is in the forefront of this new 
paradigm for teaching.    
Interview Part I appeared in the March 2009 issue
and is available at: http://jdc.jefferson.edu/hpn. 
Interviews conducted and edited by 
Emily Frelick, MS 
Project Director, Continuing Professional Education 
Jefferson School of Poulation Health
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The Mayo Clinic Health Policy Center
National Symposium on Medical and Health Education Reform
April 26, 2009 
The Mayo Clinic convened a National Symposium 
on Medical and Health Education Reform in 
Rochester, Minnesota. Health care professionals 
and educators from a variety of disciplines were 
in attendance, with the goal of developing a list of 
recommendations to support the reform agenda.
Dr. Denis Cortese, president and CEO of the Mayo  
Clinic, opened the symposium by presenting  
the 4 cornerstones of health reform: 1) create 
value, 2) coordinate care, 3) reform the payment 
system, and 4) provide health insurance for all.  
Meaningful education for health professionals  
is an important factor in achieving these goals 
and in improving the overall quality and safety 
of health care. This includes interdisciplinary 
education focused on teamwork and  
care coordination. 
Key takeaway messages from the symposium 
include the need for: a shared vision; development 
of competencies that lead to progress toward 
goals; assessments that adequately measure 
performance; educational opportunities  
in training and in practice to support and 
reinforce an integrated delivery system; and  
a common language and communication  
tools across disciplines.   
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One of our new degree programs is a Master of 
Science in Healthcare Quality and Safety. Students 
who complete this degree will be able to apply 
advanced management and leadership skills 
to develop approaches that address problems 
related to the measurement and improvement of 
healthcare quality and patient safety. 
Graduates will be able to apply the quantitative 
and qualitative analytic skills they acquire in a 
variety of settings, including inpatient facilities, 
outpatient and office care, nursing home and 
home health programs, psychiatric and drug 
treatment programs, and agencies providing end-
of-life care. Our students will also find work with 
health insurance organizations, governmental 
agencies at the state and federal level, research and 
consulting firms, and advocacy organizations.
We are eagerly preparing for our first cohort of 
students, who will begin classes in September. 
Classes will be offered across three 14-week 
sessions each year, with breaks between each 
session. Our classes will be held in the evenings, 
since we expect that many of our students will be 
working full-time and attending school part-time. 
We have hosted three open house events for 
prospective students to learn more about our 
program, and also sponsored advertisements  
on public radio, in newspapers, and on 
transportation systems in Southeastern 
Pennsylvania. Also, our brochures were widely 
distributed at local events and lectures related  
to health care quality and safety. 
Applications are being taken online for the fall 
2009 and spring 2010 semesters. The admissions 
process includes a personal statement, official 
transcripts from colleges and universities 
attended, GRE scores, and two letters of 
recommendation. There is a $25 fee, and standard 
application forms to complete. There is no 
deadline; applications are being reviewed on a 
rolling basis in batches in order to provide rapid 
turnaround. Eligible candidates will be called  
in for a personal interview.   
Susan DesHarnais, PhD, MPH
Program Director 
Health Care Quality and Safety 
Jefferson School of Population Health
Complete information on the program and the 
application process is available online at http://
www.jefferson.edu/population_health/quality_
safety/, or you may call (215) 503-5305.
Master of Science in Healthcare Quality and Safety (MS-HQS)
To kick off his keynote presentation at the 18th 
Annual Dr. Raymond C. Grandon Lecture, Thomas 
J. Nasca, MD, MACP, the former Dean of Jefferson 
Medical College, had an important reminder for 
the physicians in the audience: the work they 
do produces a social good. That social good, Dr. 
Nasca continued, is the equitable distribution of 
the “good” of health care and the restoration of 
health – wherever possible to members of society.
Dr. Nasca’s lecture, “The Impact of Education on 
Healthcare Quality,” touched on the challenges 
facing medical education in the United States and 
the importance of understanding the fundamental 
roots of the medical profession.
Dr. Nasca is currently the Chief Executive Officer 
of the Accreditation Council for Graduate Medical 
Education (ACGME), a private, non-profit council 
that evaluates and accredits medical residency 
programs throughout the United States. A 
board-certified internist and nephrologist, Dr. 
Nasca received his undergraduate degree from 
the University of Notre Dame in 1971, and his 
medical degree from Jefferson Medical College in 
1975. In 1992, he joined Jefferson Medical College 
and Thomas Jefferson University Hospital as Vice 
Chairman of the Department of Medicine, where 
he directed the undergraduate and graduate 
medical education programs of the department.
Having established that healthcare is one of  
the goods of society, Dr. Nasca posited that  
social justice is what compels physicians to 
administer its distribution. Taking it one step 
further, Dr. Nasca cited the Hippocratic Oath.  
“It comes down to nine words,” Dr. Nasca said, 
“these things I do solemnly swear, upon my 
honor – the last nine words of the Hippocratic 
Oath compels us to do this.”
In order to improve quality and safety outcomes, 
Dr. Nasca suggested physicians look to Tiger 
Woods as a role model. Woods, the number one 
golfer in the world, is known for grueling practice 
sessions where he’ll hit the same difficult shot – a 
buried lie behind a tree, for example – 100 times 
before moving on to another, which he will also 
hit 100 times. Physicians, Dr. Nasca said, don’t 
practice challenging situations intentionally; they 
practice circumstantially. Medical students are 
encouraged to study, Dr. Nasca noted, but there  
is more to medicine than knowledge.
While healthcare professionals must always  
strive for improvement, Dr. Nasca concluded,  
it is important to remember that the quality  
of healthcare provided in academic medical 
centers is “statistically, significantly better in  
every metanalysis” than what is provided in  
non-teaching hospitals. “We should be proud  
of what we do because we do it well,” Dr. Nasca  
said. “That’s what we’re committed to. We’re 
committed to continuing excellence.”   
To listen to an audio recording of this lecture visit: 
http://jdc.jefferson.edu/hplectures/6/. 
The Impact of Education on Health Care Quality 
The 18th Annual Dr. Raymond C. Grandon Lecture
Thomas J. Nasca, MD, MACP
May 7, 2009
Change Your Life.  
Change Health Care.
• Master of Public Health (MPH)
• Master of Science in Health Policy (MS-HP)
•  Master of Science in Healthcare Quality  
and Safety (MS-HQS)
Exemplary academic programs preparing  
global leaders to improve population  
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Too frequently, patients with the greatest health 
care needs have the least ability to comprehend, 
access, and navigate the U.S. health care system. 
A variety of factors, including: low educational 
levels (and resultant issues regarding literacy in 
general and health literacy in particular); limited 
English proficiency (LEP); poverty; and a lack 
of knowledge on the part of the practitioner 
towards patients’ cultural beliefs and practices, 
can exacerbate this chasm between the healthcare 
consumer and the provider. It can be difficult 
and time-consuming for providers to help some 
patients to understand how best to participate  
in their own care. Patient navigators were 
created to provide appropriate support to this 
patient population in an effort to improve their 
health outcomes.
Patient navigators may be community health 
workers, lay health educators, peer health 
promoters, medical assistants or nurses who 
serve as liaison between patients and providers 
to promote health among groups that may lack 
access to adequate health care. The purpose of 
a Patient Navigator is to help reduce health care 
disparities; facilitate communication between 
patients and providers; assist patients in 
overcoming barriers to care; shape perceptions 
individuals may have about disease and specific 
health-related behaviors; provide outreach 
services and educational support; and offer 
culturally and linguistically competent assistance.
In 1989 Dr. Harold Freeman, a surgical oncologist 
at Harlem Hospital, became concerned over 
the large numbers of women from the local 
community presenting with late-stage breast 
cancer, despite the availability of routine screening 
for the disease. As the National President of the 
American Cancer Society, he conducted a series of 
hearings throughout the US to get feedback from 
community members about the impact of cancer 
on their lives. After hearing common accounts of 
significant barriers to care, he determined that the 
obstacles for cancer prevention, early detection, 
treatment and support were surmountable. 
In 1990, Dr. Freeman created the first “patient 
navigation” program at Harlem Hospital Center 
in New York City, funded by a grant from the 
American Cancer Society1.
In 2005, policymakers came together to support 
the Patient Navigator Outreach and Chronic 
Disease Prevention Act of 2005 (Public Law  
109-18). With unanimous support in Congress, 
and under the leadership of Senator Robert 
Menendez (D-NJ), the Act amended the Public 
Health Service Act and became Public Law, 
authorizing the Secretary of Health and Human 
Services to make grants through 2010 for the 
development of patient navigator programs.   
A total of $25 million was awarded over five 
years for patient navigator programs through the 
Community Health Centers at Health Resources 
and Services Administration (HRSA), the Office  
of Rural Health Policy, the National Cancer 
Institute (NCI), and the Indian Health Service.2 
The overall purpose of the funding is to  
determine if patient navigators help reduce 
barriers to access to care and improve health care 
outcomes in underserved patient populations.
Research has shown that patient navigator 
interventions produce greater rates of screening 
and follow-up on diagnosis, resulting in better 
health outcomes. For example, in a study on 
colorectal cancer screening within a large urban 
hospital, two patient navigators were hired 
for a study period. Broken appointment rates 
went from 67% to 5% in one month, with the 
likelihood of keeping the appointment for the 
colonoscopy increasing by nearly three times3. 
Another colorectal cancer screening study within 
a minority community health setting compared 
two groups of patients with similar demographic 
characteristics who were recommended 
colonoscopy services by their physicians. The 
patients from the navigator-assisted group had a 
15.8% compliance rate, compared with only 5% in 
the non-navigator-assisted group. The navigator-
assisted group also achieved higher rates of fecal 
occult blood test completion than the non-
navigator-assisted group (42.1% vs. 25%).4 Ronald 
Myers, PhD, DSW, Professor in the Department of 
Medical Oncology at Jefferson Medical College, 
is currently leading a patient navigation project 
funded by the NCI Center for Reducing Cancer 
Health Disparities. Dr. Myers’ study, Increasing 
Colon Cancer Screening in Primary Care Among 
African Americans, seeks to determine the impact 
of preference-based message tailoring navigation 
on colorectal cancer screening in primary care at a 
population level. Einstein is a participating site for 
the study, with investigators from the Center for 
Urban Health Policy and Research serving as part 
of the research team.
In the studies mentioned, Patient Navigator 
Programs helped reduce health care disparities 
by facilitating communication between patients 
and providers; assisting patients in overcoming 
barriers to care; providing outreach services 
and educational support; and offering culturally 
and linguistically competent assistance. Patient 
navigator programs that yield sustained long-term 
clinical benefits and improve health outcomes and 
compliance are likely to also provide economic 
benefits to our health system. By funding programs 
that target underserved patient populations, the 
Patient Navigator Act of 2005 has the potential to 
contribute to improved access and efficiency of 
care and engage patients into taking a more active 
and informed role in their own health care.   
Natalia M. Urrea, BA, Health Policy Intern*
Einstein Center for Urban Health Policy  
and Research 
Albert Einstein Healthcare Network
*  This work was completed while Ms. Urrea was an intern at the Center. 
The Patient Navigator Outreach and Chronic Disease Prevention
Act of 2005: A bipartisan approach to improving access to care
and addressing health disparities
RefeRences
1.    Backgrounder. Harold P. Freeman Patient Navigation Institute. The Harold P. Freeman Institute for Patient Navigation Web site.  http://www.hpfreemanpni.org/. Accessed November 10, 2008.
2.    GovTrack.us. H.R. 1812--109th Congress (2005). Patient Navigator Outreach and Chronic Disease Prevention Act of 2005.  Federal legislation database Web site. http://www.govtrack.us/
congress/bill.xpd?bill=h109-1812.  Accessed Nov 10, 2008.
3.    Nash D, Azeez S, Vlahov D, Schori M. Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting. J Urban Health. 2006 March;83(2):231-43. http://
www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2527164. Accessed October 13, 2008.
4.    Jandorf L, Gutierrez Y, Lopez J, Christie J, Itzkowitz SH. Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health. 2005 
June;82(2):216-24. http://www.springerlink.com/content/m6h4635852004x26/fulltext.pdf. Accessed October 13, 2008.
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(12)  e. Near 40th place       (13)  e. 40 to 50 million
On April 21st, JSPH sponsored an event at the 
National Press Club in Washington, DC entitled: 
“Regulation of Follow-on Biologics: Ensuring Quality 
and Patient Safety.” Supported by an unrestricted 
educational grant from sanofi-aventis, the event 
brought together a wide range of experts in 
the medical field including doctors, scientists, 
economists and others who discussed the quality 
and safety issues surrounding the creation of a 
regulatory pathway to bring follow-on biologic drugs 
to market in the United States.  
Featured speakers included: Michael McCaughan, 
Editor in Chief of the Pink Sheet; Ann Witt, JD, Health 
Counsel to Rep. Henry A. Waxman; Brian Harvey, 
MD, PhD, VP, Regulatory Policy, sanofi-aventis; Terry 
Hisey, Vice Chairman, U.S. Life Sciences Leader, 
Deloitte LLP; and Geno Merli, MD, FACP, FHM, Chief 
Medical Officer, Thomas Jefferson University Hospital 
and Director, Jefferson Center for Vascular Diseases at 
Jefferson Medical College.
Research and development costs for biologics 
are very high and, as a result, therapy with these 
agents for patients with chronic diseases is very 
expensive.  Because these products are derived by 
modifying living organisms, the end product is 
especially sensitive to damage or contamination, 
and small differences in the manufacturing 
process may have unforeseen and unintended 
effects on therapeutic action. 
There is a movement to spur the development of 
“follow-on” biologics (FOBs) similar to the original 
products in an effort to improve access and lower 
overall costs to the health care system. Congress is 
intent on passing legislation enabling the Food and 
Drug Administration (FDA) to develop a regulatory 
pathway for FOBs similar to the pathway for generic 
forms of traditional drugs.  Well crafted legislation for 
FOBs will afford an opportunity to reduce drug costs 
and make better quality healthcare more affordable  
for millions of American families.
On April 21st, JSPH sponsored an event at the 
National Press Club in Washington, DC entitled: 
“Regulation of Follow-on Biologics: Ensuring Quality 
and Patient Safety.” Supported by an unrestricted 
educational grant from sanofi-aventis, the event 
brought together a wide range of experts in 
the medical field including doctors, scientists, 
economists and others who discussed the quality 
and safety issues surrounding the creation of a 
regulatory pathway to bring follow-on biologic drugs 
to market in the United States.  
Featured speakers included: Michael McCaughan, 
Editor in Chief of the Pink Sheet; Ann Witt, JD, Health 
Counsel to Rep. Henry A. Waxman; Brian Harvey, 
MD, PhD, VP, Regulatory Policy, sanofi-aventis; Terry 
Hisey, Vice Chairman, U.S. Life Sciences Leader, 
Deloitte LLP; and Geno Merli, MD, FACP, FHM, Chief 
Medical Officer, Thomas Jefferson University Hospital 
and Director, Jefferson Center for Vascular Diseases at 
Jefferson Medical College.
Research and development costs for biologics are 
very high and, as a result, therapy with these agents 
for patients with chronic diseases is very expensive.  
Because these products are derived by modifying 
living organisms, the end product is especially 
sensitive to damage or contamination, and small 
differences in the manufacturing process may have 
unforeseen and unintended effects on therapeutic 
action. 
There is a movement to spur the development of 
“follow-on” biologics (FOBs) similar to the original 
products in an effort to improve access and lower 
overall costs to the health care system. Congress is 
intent on passing legislation enabling the Food and 
Drug Administration (FDA) to develop a regulatory 
pathway for FOBs similar to the pathway for generic 
forms of traditional drugs.  Well crafted legislation for 
FOBs will afford an opportunity to reduce drug costs 
and make better quality healthcare more affordable 
for millions of American families.
Currently, there are competing bills under 
consideration in the House; one authored by Rep. 
Henry A. Waxman (D-Calif.), Chairman of the 
House Energy and Commerce Committee, and the 
other drafted by Rep. Anna Eshoo (D-Calif.).  In the 
Senate, Charles Schumer (D-NY) has introduced a 
companion to the Waxman proposal. 
At the conference, there was broad support for greater 
accessibility of FOBs.  However, significant concerns 
were expressed for patient-safety, “interchangeability” 
problems and product testing issues that must be 
thoroughly addressed.
Some key themes on patient safety which emerged 
from the event are as follows:
1.   Patient safety must be the number one priority, 
including adequate safety testing prior to the 
approval of any FOB. 
2.   The US should adopt some of the more successful 
and proven provisions of European regulation, 
such as its clarity around the circumstances and 
extent of testing required of FOBs. 
3.   An FOB approval pathway must be comprehensive 
and recognize the complex nature of all 
biologic medications, including proteins and 
polysaccharides.
4.   Biologic efficacy is not the same as biologic 
effectiveness.  FOBs must be evaluated for patient 
outcomes.
The outcome of this debate is likely to have far-
reaching implications with regard to access, cost, safety, 
and therapeutic impact for thousands of patients with 
serious, life-threatening, and chronic diseases.     
The conference webcast has been archived and can be 
accessed online at:   
www.visualwebcaster.com/FOB-Policy-Forum.
Follow-On Biologics, Patient Safety and Policy, 
Focus of JSPH Program in DC 
National Press Club
April 21, 2009 
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The United States Constitution’s separation 
of authorities between our national and state 
governments, coupled with an historically 
significant role for the private versus the public 
sector, produces a tale of too many moving 
parts. Health is a state responsibility and 
federal involvement is, with some exceptions, a 
consequence of programs that rely on federal 
funding. The complexity of this relationship was 
presented by Alan Lyles, ScD, MPH,  a Visiting 
Professor in the Jefferson School of Population 
Health and the Henry A. Rosenberg Professor of 
Public, Private and Nonprofit Partnerships at the 
University of Baltimore. 
Dr. Lyles described the pastiche of market-based 
health insurance, accrediting authorities and 
care provision that precludes a unified – or 
even coherent – national health policy. Instead, 
maintaining a balance is more like pushing 
string – it is achieved through contractual, 
financing and regulatory procedures rather than 
direct authority. This arrangement can lead to 
innovation in health care services, but it can also 
pose competing pressures on participants. The 
marketplace has a short-term horizon and is 
accountable to shareholders for specific financial 
results. By contrast, government policies reflect 
a longer horizon and are based on equity and 
efficiency goals. The accidents of political and 
economic history rather than planned rational 
design produced the unwieldy health care system 
that currently exists. Its costs, inefficiencies, even 
pathologies, have led to an emphasis on evidence-
based decisions.  Where the politics of health care 
reform seem to have a 1,000 points of ‘no,’ the 
cost of not changing appears unsustainable. This 
describes the perennial condition confronting 
health care reformers. In summary, the collapse of 
our economy, the disappearance of employment-
based insurance and the urgency of American 
industry’s regaining global competitiveness are 
tipping points that may propel significant change 
in the tottering balance between public and 
private sector roles.    
The Public-Private Balance in Healthcare: Political and Economic Tipping Points  
C. Alan Lyles, ScD, MPH 
Henry A. Rosenberg Professor of Public, Private, and Nonprofit Partnerships  
University of Baltimore
March 11, 2009
The Impact of Serious Medication Errors for Health Care Providers 
Zane Robinson Wolf, PhD, RN, FAAN 
Dean and Professor 
School of Nursing, LaSalle University
April 8, 2009 
Medication errors have the potential to cause 
serious harm to patients. What is often not 
considered is the profound impact these errors 
can also have on the personal and professional 
psyche of health care providers. Zane Robinson 
Wolfe, PhD, RN, FAAN, Dean and Professor of  
La Salle University’s School of Nursing, presented 
her extensive research on medication errors, 
including the historical and cultural context of 
responses to errors. 
Dr. Wolfe first explained the framework and 
interplay of the landscape for errors and 
subsequent consequences. Health care is stressful 
work performed in high-consequence systems 
where there is a significant potential for error. The 
level of personal and professional responsibility 
for patient care, and the expectations surrounding 
these responsibilities, carries a certain weight 
and burden. Health care errors are in complete 
conflict with the goals of alleviating suffering 
and preventing illness. Additionally, the notion 
of a perfect nurse or doctor is a model that is 
reinforced through education and peer approval.  
Traditionally, there has been a culture of 
blame and silence related to error.  Some of the 
consequences of this culture are underreporting 
of error events and clinician self-blame. This 
culture has also served to hinder meaningful 
improvements in practices and systems. 
Dr. Wolfe also described research related to  
the disclosure of errors. Patients not only want  
to be told about errors during their care, they  
want to know why and how the error occurred, 
and what will be done in the future to prevent 
similar errors. Patients and family members want 
a sincere, prompt, and compassionate apology. 
There is sometimes a disparity between patients 
and relatives and their desire for open, honest 
communication and what physicians actually do. 
Physician reluctance to fully disclose is often based 
on their own emotions, discomfort, and fears. 
The emotional impact of an error on a provider is 
not something that is typically openly discussed. 
Dr. Wolfe explored the psychological dynamics 
that often take place, even long after an error has 
been made. There is often a barrage of emotions 
from doubt, self-blame, sleep loss, lack of job 
confidence, anxiety, embarrassment, guilt, and 
remorse. On a more practical level, providers 
may face real consequences, such as probation, 
suspension, termination, or criminal prosecution. 
Dr. Wolfe discussed the process that takes place 
when an error has occurred and she emphasized 
the need for support, education, resources, and 
counseling. Ideally, organizational approaches 
such as Employee Assistance Programs (EAP)  
and team interventions help to diminish the  
long-term emotional impact and affect change.   
Health Policy Forums
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Upcoming Health Policy Forums
innovative Approaches to medical education 
September 9, 2009 
M. Brownell Anderson, M, Ed  
Senior Director, Education Affairs   
Association of American Medical Colleges  
Philadelphia’s Public health Priorities  
and initiatives: implications for  
improving the health of Vulnerable  
Populations
Wednesday, october 14, 2009 
Donald Schwarz, MD, MPH  
Deputy Mayor, Health and Opportunity  
Philadelphia Department of Public Health
Building Patient Centered medical homes 
in America’s Poorest City – Camden, NJ 
November 11, 2009 
Jeffrey Brenner, MD 
Medical Director 
Camden Coalition of Healthcare Providers
Achieving Cultural Competency: 
Using a Case-Based Approach for  
teaching and Learning
december 9, 2009
Lisa Hark, PhD, RD 
Project Manager, Online Medical Education 
Wills Eye Institute
Horace M. DeLisser, MD 
Associate Dean, Spirituality and Cultural Competency 
University of Pennsylvania School of Medicine
Continued on page 14
Please note all forums will take place at:  
Bluemle Life Science Building 
233 South 10th Street, Room 101 
Philadelphia, PA 19107  
8:30 a.m. – 9:30 a.m.
For more information contact:  
(215) 955-6969  
 
Book Review
M Robinson, Novelli A, Pearson C, Norris L, eds.  
Global Health and Global Aging 
San Francisco, CA: Jossey-Bass; 2007. 
Global demographic transformation in the 
21st century will most likely be characterized 
by population aging. In 2006, 11 percent of the 
world’s population was 65 years or older. This 
number is expected to reach 22 percent (nearly 
two billion people) by 2050. Global Health and 
Global Aging is a comprehensive report that 
offers diverse positions and perspectives from 41 
international experts, and a thought-provoking 
foreword by Robert N. Butler, MD, a leading 
authority on aging and President and CEO of 
International Longevity Center - USA.  
The book is organized into five major sections. 
Part One, The World and Its Aging Population, 
presents an overview of the topic, including 
a global synopsis of demographic trends and 
a discussion of international policies and 
institutional leadership challenges affecting the 
aging population. 
Part Two, Countries with High Rates of Longevity, 
highlights the opportunities and successes of 
countries with record high rates of longevity.  
Chapter 8, by Pekka Puska, the director general 
of the National Public Health Institute of Finland 
(KTL), describes well-planned actions in Finland 
that had a positive effect on lifestyles and led to 
a decrease in chronic diseases, thereby resulting 
in increased health, functional capacity, and well-
being in old age. 
As is evident in Part Three, Countries Facing 
Rapid Population Aging in the Next Twenty to 
Thirty Years, issues of aging and global health 
facing different countries can take a dramatically 
different shape. While the average life expectancy 
in Europe is 75, it hovers around 50 years in the 
developing world largely due to poverty, malaria, 
TB, AIDS, and vaccine-preventable diseases. But as 
the fight against infectious diseases gains ground, 
older populations will grow in the developing 
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Left to right: Nicole M. Cobb, Program Director; Christine Chung, Stephanie Staples, Ashley Darcy, Noel Ramirez, Elizabeth Daly, Cameron Bass, Megan Riley, and 
Program Chair, David B. Nash, MD, MBA (Dean, Jefferson School of Population Health). Not pictured: Yewah Jung, Erin Lewis, and Anita Yang. 
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world as well, and chronic conditions will come to 
the forefront. 
Developing countries will be presented with  
a unique set of challenges as their populations  
age mainly because, as Alex Kalache, chief of  
the World Health Organization’s Aging and 
Life Course Program, states in Part Four, 
“industrialized countries became rich before 
they became old, while developing countries will 
become old before they become rich.” Entitled 
Leaders in Research and Innovative Programs, 
Part Four highlights novel transportation, 
housing, financing, and education programs 
developed in government, business, and social 
sectors to create healthy environments and 
improve the healthcare and quality of life of the 
aging population. The experiences and research 
programs discussed can serve as examples for 
countries seeking sustainable solutions to the 
issues facing their aging population. 
Part Five, Epilogue: The Road Ahead, looks 
to the future and discusses country-specific 
opportunities for the improvement of programs, 
attitudes, and policies developed for their  
aging population. 
There are a few key themes that emerge 
throughout the book. First, each culture offers 
unique resources and insights to the new realities 
of its aging population. Most importantly, global 
health and aging is an international phenomenon 
and demands a new international perspective and 
collaboration. To promote better health, countries 
around the world need to draw from the collective 
experience and wisdom to strengthen their health 
systems with an appropriate emphasis on the 
needs of their own aging population. 
Global Health and Global Aging is a wonderful 
resource for those seeking to better understand 
the circumstances, challenges, threats, and 
opportunities facing aging populations worldwide. 
Besides being a well organized volume, written by 
high-profile public policy experts, it might satisfy 
the reader to know that all the book’s royalties will 
go directly to AARP, the non-profit advocacy and 
policy organization dedicated to the needs and 
interests of those 50 and older.   
Reviewed by 
Safiya Abouzaid, PharmD 
Pharmacoeconomics and Outcomes  
Research Fellow 
Jefferson School of Population Health
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